Pulmonary Disease, Chronic Obstructive
940
18
29
757
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
316 trials with published results (34%)
Research Maturity
757 completed trials (81% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.2%
49 terminated out of 940 trials
93.9%
+7.4% vs benchmark
29%
271 trials in Phase 3/4
42%
316 of 757 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 757 completed trials
Clinical Trials (940)
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
Tiotropium/Salmeterol Inhalation Powder in COPD
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Generative AI for Medication Counselling and Adherence in Community Pharmacies
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry
Innate Immunity in Ozone-induced Airway Inflammation in COPD
Involvement of Skeletal Muscle Fibrocytes in sarcOpenia in Patients With Chronic ObstRuctive Pulmonary Disease
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
Development and Validation of the GLORI-COPD Score
Internet-based Rehabilitation Aftercare Focusing on Physical Activity Promotion in Persons With COPD
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations